Having similar properties on targeting membrane glycoprotein overexpressed on prostate cancer cell surface with comparable detection sensitivity, common PSMA agents should exhibit similar image characteristics within their optimal uptake periods in which the working principles of the contouring algorithms are based on. The gene discussed is FOLH1; the disease is prostate cancer.